doi.org/10.1016/s1470-2045(20)30525-8

Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial

..., Inho Kim
25
The Lancet Oncology35.90
Volume: 21, Issue: 12, Pages: 1630 - 1642
Published: Oct 30, 2020
Paper Fields
Paper Details
Title
Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial
DOI
doi.org/10.1016/s1470-2045(20)30525-8
Published Date
Oct 30, 2020
Journal
The Lancet Oncology
Volume
21
Issue
12
Pages
1630 - 1642
© 2026 Pluto Labs All rights reserved.